The effectiveness of 1% pimecrolimus cream in the treatment of oral erosive lichen planus

Journal of Periodontology

Volumn 76, Issue 4, 2005, Pages 627-635

  Swift, Julie C ^a,b   Rees, Terry D ^b   Plemons, Jacqueline M ^b   Hallmon, William W ^b   Wright, John C ^b  

^a Graduate Periodontics ^*

^b BAYLOR COLLEGE OF DENTISTRY   (United States)

Author keywords

Lichen planus; Oral drug therapy; Pimecrolimus therapeutic use

Indexed keywords

PIMECROLIMUS; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BLOOD SAMPLING; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HUMAN; LICHEN PLANUS; MALE; MOUTH DISEASE; MOUTH ULCER; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME; VISUAL ANALOG SCALE; WILCOXON SIGNED RANKS TEST;

ADULT; AGED; ANALYSIS OF VARIANCE; DOUBLE-BLIND METHOD; FACIAL PAIN; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; OINTMENTS; PAIN MEASUREMENT; PILOT PROJECTS; STATISTICS, NONPARAMETRIC; TACROLIMUS;

EID: 19044396016     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2005.76.4.627     Document Type: Article

References (43)

1. Silverman SJR, Gorsky M, Lozada-Nur F, Gianotti K. A prospective study of findings and management in 214 patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 1991;72:665-670.
2. Scully C, El-kom E. Lichen planus: A review and update in pathogenesis. J Oral Pathol Med 1985;14:431-438.
3. Thorn JJ, Holmstrup P, Rindrum J, Pindborg JJ. Course of various clinical forms of oral lichen planus. A prospective follow-up study of 611 patients. J Oral Pathol 1988; 17:213-218.
4. Lozada F, Silverman J. Topically applied fluocinonide in an adhesive base in the treatment of oral vesiculoerosive diseases. Arch Dermatol 1980;116:190-201.
5. Carbone M, Carrozzo M, Castellano S, Conrotto D, Broccoletti R, Gandolfo S. Systemic corticosteroid therapy of oral vesiculoerosive diseases (OVED). An open trial. Minerva Stomatologica 1998;47:479-487.
6. Voute AB, Schulkten EA, Langendijk PN, Kostense PJ, van der Waal I. Fluocinonide in an adhesive base for treatment of oral lichen planus. A double-blind, placebo-controlled clinical study. Oral Surg Oral Med Oral Pathol 1993;75:181-185.
7. Buajeeb W, Kraivaphan P, Pobrurksa C. Efficacy of fluocinolone acetonide gel in the treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:42-45.
8. Thongprasom K, Luangjarmekorn L, Sererat T, Taweesap W. Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus. J Oral Pathol Med 1992;21:456-458.
9. Cawson RA. Treatment of oral lichen planus with beta-methasone. Br Med J 1968;584:86-89.
10. Greenspan JS, Yeoman CM, Harding SM. Oral lichen planus. A double-blind comparison of treatment with betamethasone valerate aerosol and pellets. Br Dent J 1978;144:83-84.
11. Tyldesley WR, Harding SM. Betamethasone valerate aerosol in the treatment of oral lichen planus. Br J Dermatol 1977; 96:659-662.
12. Lozada-Nur F, Huang MZ, Zhou GA. Open preliminary clinical trial of clobetasol proprionate ointment in adhesive paste for treatment of chronic oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol 1991;71:283-287.
13. Lozada-Nur F, Miranda C, Maliksi R. Double-blind clinical trial of 0.05% clobetasol proprionate ointment in orabase and 0.05% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol 1994;77:598-604.
14. Muzio LL, della Valle A, Mignogna MD, et al. The treatment of oral aphthasous ulceration or erosive lichen planus with topical clobetasol proprionate in three preparations: A clinical and pilot study of 54 patients. J Oral Pathol Med 2001;46:228-241.
15. Carbone M, Conrotto D, Carrozzo M, Broccoletti R, Gandolfo S, Scully C. Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: A placebo-controlled and comparative study between clobetasol and fluocinonide. Oral Diseases 1999;5: 44-49.
16. Carbone M, Goss E, Carrozzo M. Systemic and topical corticosteroid treatment of oral lichen planus: A comparative study with long-term follow-up. J Oral Pathol 2003; 32:323-329.
17. Eisen D, Ellis CN, Duell EA, Griffiths CE, Voorhees JJ. Effect of topical cyclosporine rinse on oral lichen planus: A double-blind analysis. N Engl J Med 1990;323:290-294.
18. Harpenau LA, Plemons JM, Rees TD. Effectiveness of a low dose cyclosporine in the management of patients with oral erosive lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;80:161-167.
19. Lopez J, Rosello L. Cyclosporine A, an alternative to the oral lichen planus erosive treatment (in French). Bull Group Int Rech Sci Stomatol Odontol 1995;38:33-38.
20. Veller Fornasa CV, Catalano P. Effect of local application of cyclosporine in chronic ulcerative lichen planus. Dermatologica 1991;182:165.
21. Levell NJ, MacLeod RI, Marks JM. Lack of effect of cyclosporine mouthwash in oral lichen planus. Lancet 1991;337:796-797.
22. Voute AB, Schulten EA, Langendijk PN, Niebor C, van der Waal I. Cyclosporine A in an adhesive base for treatment of recalcitrant oral lichen planus. An open trial. Oral Surg Oral Med Oral Pathol 1994;78:437-441.
23. Buajeeb W, Kraivaphan P, Pobrurksa C. Efficacy of topical retinoic acid compared with topical fluocinolone acetonide in the treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:21-25.
24. Giustina TA, Stewart JC, Ellis CN, et al. Topical application of isotretinoin gel improves oral lichen planus. A double-blind study. Arch Dermatol 1986;144:83-84.
25. Baudet-Pommel M, Janin-Mercier A, Souteyrand P. Sequential immunopathologic study of oral lichen planus treated with tretinoin and etretinate. Oral Surg Oral Med Oral Pathol 1991;71:197-202.
26. Laurberg G, Geiger JM, Hjorth N, et al. Treatment of lichen planus with acitretin. A double-blind, placebo-controlled study in 65 patients. J Am Acad Dermatol 1991;24:434-437.
27. Nisengard RJ. Periodontal implications: Mucocutaneous disorders. Ann Periodontol 1996;1:401-438.
28. Wu SJ, Tanphaichitr A, Ly M. Recent advances in dermatology. Clin Podiatr Med Surg 2002;19:65-78.
29. Ling MR. Topical tacrolimus and pimecrolimus: Future directions. Semin Cutan Med Surg 2001;20:268-74.
30. Vente C, Reich K, Rupprecht R, Neumann C. Erosive mucosal lichen planus: Response to topical treatment with tacrolimus. Br J Dermatol 1999;140:338-342.
31. Morrison L, Kratochvil FJ 3rd, Gorman A. An open trial of topical tacrolimus for erosive lichen planus. J Am Acad Dermatol 2002;47:617-620.
32. Lener EV, Brieva J, Schachter M, et al. Successful treatment of erosive lichen planus with topical tacrolimus. Br J Dermatol 2001;137:419-422.
33. Olivier V, Lacour JP, Mousnier A, Garraffo R, Monteil RA, Ortonne JP. Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: An open prospective study. Arch Dermatol 2002;138:1335-1338.
34. Luger T. Treatment of immune-mediated skin diseases: Future perspectives. Eur J Dermatol 2001;11:343-347.
35. Billich A, Aschauer H, Aszodi A, Stuetz A. Percutaneous absorption of drugs used in atopic eczema: Pimecrolimus permeates less through skin than corticosteroids and tacrolimus. Int J Pharm 2004;269:29-35.
36. Eichenfield L, Lucky AW, Boguniewicz M, et al. Safety and efficacy of ASM 981 (pimecrolimus) cream 1% in the treatment of atopic dermatitis in children and adolescents. J Am Acad Dermatol 2002;46:495-504.
37. Van Leent EJ, Graber M, Thurston M, Wagenaar A, Spuls PI, Boss JD. Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis. Arch Dermatol 1998;134:805-809.
38. Huskisson ED. Visual analogue scales. In: Melzack, ed. Pain Measurement Assessment. New York: Raven Press; 1983:33-37.
39. Klanrit P, Thongprasom K, Rojanawatsirivej S, Theamboonlers A, Poovorawan Y. Hepatitis C virus infection in Thai patients with oral lichen planus. Oral Dis 2003;9:292-297.
40. Carrozzo M, Gandolfo S. Oral diseases possibly associated with hepatitis C virus. Crit Rev Oral Biol Med 2003; 14:115-127.
41. Figueiredo LC, Carrilho FJ, de Andrage HF, Migliari DA. Oral lichen planus and hepatitis C virus infection. Oral Dis 2002;8:42-46.
42. Mignogna MD, Lo Muzio L, Favia G, Mignogna RE, Carbone R, Bucci E. Oral lichen planus and HCV infection: A clinical evaluation of 263 cases. Int J Dermatol 1998;37:575-578.
43. Nagao Y, Sata M, Tanikawa K, Itoh K, Kameyama T. Lichen planus and hepatitis C virus in the northern Kyushu region of Japan. Eur J Clin Invest 1995;25:910-914.